Cargando…

Saccharomyces cerevisiae boulardii Reduces the Deoxynivalenol-Induced Alteration of the Intestinal Transcriptome

Type B trichothecene mycotoxin deoxynivalenol (DON) is one of the most frequently occurring food contaminants. By inducing trans-activation of a number of pro-inflammatory cytokines and increasing the stability of their mRNA, trichothecene can impair intestinal health. Several yeast products, especi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alassane-Kpembi, Imourana, Pinton, Philippe, Hupé, Jean-François, Neves, Manon, Lippi, Yannick, Combes, Sylvie, Castex, Mathieu, Oswald, Isabelle P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983255/ https://www.ncbi.nlm.nih.gov/pubmed/29762474 http://dx.doi.org/10.3390/toxins10050199

Ejemplares similares

Impact of two mycotoxins deoxynivalenol and fumonisin on pig intestinal health
por: Pierron, Alix, et al.
Publicado: (2016)

Statistical Integration of ‘Omics Data Increases Biological Knowledge Extracted from Metabolomics Data: Application to Intestinal Exposure to the Mycotoxin Deoxynivalenol
por: Tremblay-Franco, Marie, et al.
Publicado: (2021)

Effects of Mycotoxins on the Intestine
por: Alassane-Kpembi, Imourana, et al.
Publicado: (2019)

Intestinal toxicity of the type B trichothecene mycotoxin fusarenon-X: whole transcriptome profiling reveals new signaling pathways
por: Alassane-Kpembi, Imourana, et al.
Publicado: (2017)

Nivalenol Has a Greater Impact than Deoxynivalenol on Pig Jejunum Mucosa in Vitro on Explants and in Vivo on Intestinal Loops
por: Cheat, Sophal, et al.
Publicado: (2015)

Impact of mycotoxin on immune response and consequences for pig health
por: Pierron, Alix, et al.
Publicado: (2016)

Effects of Saccharomyces cerevisiae or boulardii yeasts on acute stress induced intestinal dysmotility
por: West, Christine, et al.
Publicado: (2016)

Effect of Deoxynivalenol and Other Type B Trichothecenes on the Intestine: A Review
por: Pinton, Philippe, et al.
Publicado: (2014)

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment
por: Appel-da-Silva, Marcelo C., et al.
Publicado: (2017)

Effect of Feeding Saccharomyces cerevisiae boulardii CNCM I-1079 to Sows and Piglets on Piglets’ Immune Response after Vaccination against Actinobacillus pleuropneumoniae
por: Bravo de Laguna, Fernando, et al.
Publicado: (2022)

Different specificities of two aldehyde dehydrogenases from Saccharomyces cerevisiae var. boulardii
por: Datta, Suprama, et al.
Publicado: (2017)

Saccharomyces cerevisiae boulardii accelerates intestinal microbiota maturation and is correlated with increased secretory IgA production in neonatal dairy calves
por: Rostoll Cangiano, Lautaro, et al.
Publicado: (2023)

Probiotic Saccharomyces boulardii in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Draft Genome Sequence of the Probiotic Yeast Saccharomyces cerevisiae var. boulardii Strain ATCC MYA-796
por: Batista, T. M., et al.
Publicado: (2014)

Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory
por: Jin, Yerin, et al.
Publicado: (2021)

Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients
por: Sulik-Tyszka, Beata, et al.
Publicado: (2017)

Biocontainment strategies for in vivo applications of Saccharomyces boulardii
por: Hedin, Karl Alex, et al.
Publicado: (2023)

Impact of Deoxynivalenol on the Intestinal Microflora of Pigs
por: Waché, Yann J., et al.
Publicado: (2008)

Dietary Saccharomyces cerevisiae boulardii CNCM I-1079 Positively Affects Performance and Intestinal Ecosystem in Broilers during a Campylobacter jejuni Infection
por: Massacci, Francesca Romana, et al.
Publicado: (2019)

Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature
por: Atıcı, Serkan, et al.
Publicado: (2017)

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections
por: Czerucka, Dorota, et al.
Publicado: (2019)

Effects of Saccharomyces cerevisiae on alleviating cytotoxicity of porcine jejunal epithelia cells induced by deoxynivalenol
por: Liu, Yang, et al.
Publicado: (2019)

Evaluation of a Yeast Hydrolysate from a Novel Strain of Saccharomyces cerevisiae for Mycotoxin Mitigation using In Vitro and In Vivo Models
por: Bruinenberg, Paul Gerard, et al.
Publicado: (2021)

Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?
por: Pais, Pedro, et al.
Publicado: (2020)

Effect of Saccharomyces cerevisiae boulardii on sows’ farrowing duration and reproductive performance, and weanling piglets’ performance and IgG concentration
por: Sun, Haiqing, et al.
Publicado: (2022)

Saccharomyces boulardii Modifies Salmonella Typhimurium Traffic and Host Immune Responses along the Intestinal Tract
por: Pontier-Bres, Rodolphe, et al.
Publicado: (2014)

Comparison of the Effects of Enzymolysis Seaweed Powder and Saccharomyces boulardii on Intestinal Health and Microbiota Composition in Kittens
por: Zhang, Mingrui, et al.
Publicado: (2023)

The Food Contaminant Deoxynivalenol Exacerbates the Genotoxicity of Gut Microbiota
por: Payros, Delphine, et al.
Publicado: (2017)

Effect of microencapsulation on Saccharomyces cerevisiae var. boulardii viability in the gastrointestinal tract and level of some blood biochemical factors in wistar rats
por: Ghorbani-Choboghlo, Hassan, et al.
Publicado: (2019)

Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast Saccharomyces cerevisiae var. boulardii
por: Offei, Benjamin, et al.
Publicado: (2019)

Probiotic Saccharomyces cerevisiae var. boulardii supernatant inhibits survivin gene expression and induces apoptosis in human gastric cancer cells
por: Pakbin, Babak, et al.
Publicado: (2020)

An unexpected allergic reaction with Saccharomyces boulardii: a case report
por: Kartal, Ozgur, et al.
Publicado: (2014)

Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice
por: Zhou, Huan, et al.
Publicado: (2018)

Impact of Saccharomyces boulardii on jaundice in premature infants undergoing phototherapy
por: Hu, Di, et al.
Publicado: (2022)

Effect of Saccharomyces cerevisiae var. Boulardii and β-galactomannan oligosaccharide on porcine intestinal epithelial and dendritic cells challenged in vitro with Escherichia coli F4 (K88)
por: Badia, Roger, et al.
Publicado: (2012)

Saccharomyces boulardii CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review
por: Moré, Margret I, et al.
Publicado: (2018)

Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice
por: Dong, Jin-Pei, et al.
Publicado: (2019)

Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption
por: Terciolo, Chloe, et al.
Publicado: (2019)

Yeast cell wall extracts from Saccharomyces cerevisiae varying in structure and composition differentially shape the innate immunity and mucosal tissue responses of the intestine of zebrafish (Danio rerio)
por: Rawling, Mark, et al.
Publicado: (2023)

Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a review
por: Moré, Margret I, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3pknf7rgobu2peik70o4hq2mbn